Contrast media-associated nephrotoxicity

Seminars in Nephrology

Volumn 17, Issue 1, 1997, Pages 15-26

  Rudnick, Michael R ^a,b   Berns, Jeffrey S ^a,b   Cohen, Raphael M ^a,b   Goldfarb, Stanley ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b GRADUATE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CONTRAST MEDIUM; FUROSEMIDE; IONIC CONTRAST MEDIUM; MANNITOL; NONIONIC CONTRAST MEDIUM; SODIUM CHLORIDE; THEOPHYLLINE;

ACUTE KIDNEY FAILURE; CLINICAL FEATURE; CLINICAL TRIAL; DIABETES MELLITUS; DRUG INDUCED DISEASE; HEMODIALYSIS; HUMAN; HYDRATION; INTRAVENOUS DRUG ADMINISTRATION; MULTIPLE MYELOMA; NEPHROTOXICITY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

ANIMALS; CONTRAST MEDIA; HUMANS; INCIDENCE; INFUSIONS, INTRAVENOUS; KIDNEY; KIDNEY FAILURE, ACUTE; RISK FACTORS;

EID: 0031033192     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (150)

1. Hou Sh, Bushinsky DA, Wish JB, et al: Hospital-acquired renal insufficiency: A prospective study. Am J Med 74:243-248, 1983
2. Shusterman N, Strom BL, Murray TG, et al: Risk factors and outcome of hospital-acquired acute renal failure. Clinical epidemiologic study. Am J Med 83:65-71, 1987
3. Coggins CH, Fang LS-T: Acute renal failure with antibiotics, anesthetic agents, and radiographie contrast agents, in Brenner BM, Lazurus JM (eds): Acute Renal Failure, ed 2. New York, NY, Churchill Livingstone, 1988, pp 295-352
4. Berns AS: Nephrotoxicity of contrast media. Kidney Int 36:730-740, 1989
5. Bakris GL: Pathogenesis and therapeutic aspects of radiocontrast-induced renal dysfunction, in Hook JB, Goldstein RS (eds): Toxicology of the Kidney. New York, NY, Raven Press, 1993, pp 361-386
6. Barrett BJ: Contrast nephrotoxicity. J Am Soc Nephrol 5:125-137, 1994
7. Rudnick MR, Berns JS, Cohen RM, et al: Nephrotoxic risks of renal angiography: Contrast media-associated nephrotoxicity and atheroembolism - A critical review. Am J Kidney Dis 24:713-727, 1994
8. Rudnick MR, Berns JS, Cohen RM, et al: Contrast media-associated nephrotoxicity. Curr Opin Nephrol Hypertens 5:127-133, 1996
9. Katzberg RW, Morris TW, Burgener FA, et al: Renal renin and hemodynamic responses to selective renal artery catheterization and angiography. Invest Radiol 12:381-388, 1977
10. Bakris GL, Buraett JC Jr: A role for calcium in radiocontrast-induced reductions in renal hemodynamics. Kidney Int 27:465-468, 1985
11. Caldicott WJH, Hollenberg NK, Abrams HL: Characteristics of response of renal vascular bed to contrast media. Evidence of vasoconstriction induced by renin-angiotensin system. Invest Radiol 5:539-547, 1970
12. Heyman SN, Brezis M, Reubinoff CA, et al: Acute renal failure with selective medullary injury in the rat. J Clin Invest 82:401-412, 1988
13. Heyman SN, Brezis M, Epstein FH, et al: Early renal medullary hypoxic injury from radiocontrast and indomethacin. Kidney Int 40:632-642, 1991
14. Vari RC, Natarajan LA, Whitescarver SA, et al: Induction, prevention and mechanisms of contrast media-induced acute renal failure. Kidney Int 33:699-707, 1988
15. Workman RJ, Shaff MI, Jackson RV, et al: Relationship of renal hemodynamics and functional changes following intravascular contrast to the renin-angiotensin system and renal prostacyclin in the dog. Invest Radiol 18:160-166, 1983
16. Deray G, Martinez F, Cacoub P, et al: A role for adenosine calcium and ischemia in radiocontrast-induced intrarenal vasoconstriction. Am J Nephrol 10:316-322, 1990
17. Rubinger D, Hochman O, Popovitzer MM: Contrast medium (CM) induced renal failure in experimental diabetes mellitus (DM). The role of endogenous prostaglandins (PG). J Am Soc Nephrol 6:1003, 1995 (abstr)
18. Cantley LG, Spokes K, Clark B, et al: Role of endothelin and prostaglandins in radiocontrast-induced renal artery constriction. Kidney Int 44:1217-1223, 1993
19. Arend LJ, Bakris GL, Bumett JC Jr, et al: Role of intrarenal adenosine in the renal hemodynamic response to contrast media. J Lab Clin Med 110:406-411, 1987
20. Erley CM, Duda SH, Schlepakow S, et al: Adenosine antagonist theophylline prevents the reduction of glomerular filtration rate after contrast media application. Kidney Int 45:1425-1431, 1994
21. Katholi RE, Taylor GJ, McCann WP, et al: Nephrotoxicity from contrast media: Attenuation with theophylline. Radiology 195:17-22, 1995
22. Arakawa K, Suzuki H, Naitoh M, et al: Adenosine A-1 receptor antagonist, KW3902, completely prevents nonionic radiocontrast-induced renal insufficiency (RCIN) in conscious dogs with renal insufficiency. J Am Soc Nephrol 5:916, 1994 (abstr)
23. Erley CM, Burgert K, Langanke J, et al: Prevention of radiocontrast-induced nephropathy (RCIN) by adenosine antagonism. J Am Soc Nephrol 6:162, 1995 (abstr)
24. Okumura M, Miura K, Yamashita Y, et al: Role of endothelium-derived relaxing factor in the in vivo renal vascular action of adenosine in dogs. J Pharmacol Exp Ther 260:1262-1267, 1992
25. Brezis M, Heyman SN, Dinour D, et al: Role of nitric oxide in renal medullary oxygenation. Studies in isolated and intact rat kidneys. J Clin Invest 88:390-395, 1991
26. Touati C, Idée JM, Deray G, et al: Modulation of the renal effects of contrast media by endothelium-derived nitric oxide in the rat. Invest Radiol 28:814-820, 1993
27. Erley CM, Burgert K, Langanke J, et al: A novel animal model of radiocontrast-induced nephropathy (RCIN). J Am Soc Nephrol 6:462, 1995 (abstr)
28. Idée JM, Beaufils H, Bonnemain B: lodinated contrast media-induced nephropathy: Pathophysiology, clinical aspects and prevention. Fundam Clin Pharmacol 8:193-206, 1994
29. Margulies KB, Hildebrand FL, Heublein DM, et al: Radiocontrast increases plasma and urinary endothelin. J Am Soc Nephrol 2:1041-1045, 1991
30. Heyman SN, Clark BA, Kaiser N, et al: Radiocontrast agents induce endothelin release in vivo and in vitro. J Am Soc Nephrol 3:58-65, 1992
31. Kubo M, Hirakata H, Okuda S, et al: Increase in urinary endothelin excretion after radiocontrast infusion (RC) in patients with chronic renal failure (CRF). J Am Soc Nephrol 6:1000, 1995 (abstr)
32. Heyman SN, Clark BA, Cantley L, et al: Effects of ioversol versus iothalamate on endothelin release and radiocontrast nephropathy. Invest Radiol 28:313-318, 1993
33. Brooks DP, DePalma PD: Blockade of radiocontrastinduced nephrotoxicity by the edothelin receptor antagonist, SB209670. Nephron 72:629-636, 1996
34. Kohan DE, Padilla E: Osmolar regulation of endothelin-1 production by rat inner medullary collecting duct. J Clin Invest 91:1235-1240, 1993
35. Yang T, Terada Y, Nonguchi H, et al: Effect of hyperosmolality on production and mRNA expression of ET-1 in inner medullary collecting duct. Am J Physiol 264:F684-F689, 1993
36. Oldroyd S, Slee S-J, Haylor J, et al: Role for endothelin in the renal responses to radiocontrast media in the rat. ClinSci 87:427-434, 1994
37. Oldroyd SD, Haylor JL, Morcos SK: The acute effect of ioversol on kidney function: Role of endothelin. Eur J Radiol 19:91-95, 1995
38. Pollock DM, Polakowski JS: Beneficial effect of ETA receptor blockade in radiocontrast-induced nephropathy in the rat. J Am Soc Nephrol 6:667, 1995 (abstr)
39. Bakris GL, Lass N, Gaber AO, et al: Radiocontrast medium-induced declines in renal function: A role for oxygen free radicals. Am J Physiol 258:F115-F120, 1990
40. Parvez Z, Rahman MA, Moncada R: Contrast media-induced lipid peroxidation in the rat kidney. Invest Radiol 24:697-702, 1989
41. Yoshioka T, Fogo A, Beckman JK: Reduced activity of antioxidant enzyme underlies contrast media-induced renal injury in volume depletion. Kidney Int 41:1008-1015, 1992
42. Moreau J-F, Droz D, Noel L-E, et al: Tubular nephrotoxicity of water-soluble iodinated contrast media. Invest Radiol 15:S54-S60, 1980
43. Deray G, Dubois M, Martinez F, et al: Renal effects of radiocontrast agents in rats: A new model of acute renal failure. Am J Nephrol 10:507-513, 1990
44. Battenfeld R, Khater AER, Drommer W, et al: loxaglate-induced light and electron microscopic alternations in the renal proximal tubular epithelium of rats. Invest Radiol 26:35-39, 1991
45. Golman K, Almén T: Contrast media-induced nephrotoxicity. Survey and present state. Invest Radiol 20:S92-S97, 1985
46. Humes HD, Hunt DA, White MD: Direct toxic effect of the radiocontrast agent diatrizoate on proximal tubule cells. Am J Physiol 252:F246-F255, 1987
47. Messana JM, Cieslinski DA, Nguyen VD, et al: Com-parison of the toxicity of the radiocontrast agents iopamidol and diatrizoate to rabbit renal proximal tubule cells in vitro. J Pharmacol Exper Ther 244:1139-1144, 1988
48. Andersen K-J, Christensen EI, Vik H: Effects of iodinated x-ray contrast media on renal epithelial cells in culture. Invest Radiol 29:955-962, 1994
49. Heyman SN, Rosen S, Brezis M: Radiocontrast nephropathy: A paradigm for the synergism between toxic and hypoxic insults in the kidney. Exp Nephrol 2:153-157, 1994
50. Liss P, Nygren A, Olsson U, et al: Effects of contrast media and mannitol on renal medullary flow and red cell aggregation in the rat kidney. Kidney Int 49:1268-1275, 1996
51. Diaz-Buxo JA, Wagoner RD, Hattery RR, et al: Acute renal failure after excretory urography in diabetic patients. Ann Intern Med 83:155-158, 1975
52. Teruel JL, Marcen R, Onaindia JM, et al: Renal function impairment caused by intravenous urography. Arch Intern Med 141:1271-1274, 1981
53. Fang LS-T, Sirota RA, Ebert TH, et al: Low fractional excretion of sodium with contrast media-induced acute renal failure. Arch Intern Med 140:531-533, 1980
54. Byrd L, Sherman RL: Radiocontrast-induced acute renal failure: A clinical and pathophysiologic review. Medicine 58:270-279, 1979
55. VanZee BE, Hoy WE, Talley TE, et al: Renal injury associated with intravenous pyelography in nondiabetic and diabetic patients. Ann Intern Med 89:51-54, 1978
56. Harris KG, Smith TP, Cragg AH, et al: Nephrotoxicity from contrast material in renal insufficiency: Ionic versus nonionic agents. Radiology 179:849-852, 1991
57. Taliercio CP, Vlietstra RE, Ilstrup DM, et al: A randomized comparison of the nephrotoxicity of iopamidol and diatrizoate in high risk patients undergoing cardiac angiography. J Am Coll Cardiol 17:384-390, 1991
58. Barrett BJ, Parfrey PS, Vavasour HM, et al: Contrast nephropathy in patients with impaired renal function: High versus low osmolar media. Kidney Int 41:1274-1279, 1992
59. Moore RD, Steinberg EP, Powe NR, et al: Nephrotoxicity of high-osmolality versus low-osmolality contrast media: Randomized clinical trial. Radiology 182:649-655, 1992
60. Rudnick MR, Goldfarb S, Wexler L, et al: Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: A randomized trial. Kidney Int 47:254-261, 1995
61. Carvallo A, Rakowski TA, Argy WP Jr, et al: Acute renal failure following drip infusion pyelography. Am J Med 65:38-45, 1978
62. Manske CL, Sprafka JM, Strony JT, et al: Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 89:615-620, 1990
63. Harkonen S, Kjellstrand CM: Exacerbation of diabetic renal failure following intravenous pyelography. Am J Med 63:939-946, 1977
64. Shaft T, Chou S-Y, Porush JG, et al: Infusion intravenous pyelography and renal function: Effects in patients with chronic renal insufficiency. Arch Intern Med 138:1218-1221, 1978
65. Mudge GH: Nephrotoxicity of urographie radiocontrast drugs. Kidney Int 18:540-552, 1980
66. Harkonen S, Kjellstrand C: Contrast nephropathy. Am J Nephrol 1:69-77, 1981
67. Anderson RJ, Linas SL, Berns AS, et al: Nonologuric acute renal failure. N Engl J Med 296:1134-1137, 1977
68. Weinrauch LA, Healy RW, Leland OS, et al: Coronary angiography and acute renal failure in diabetic azotemia nephropathy. Ann Intern Med 86:56-59, 1977
69. Taliercio CP, Vlietstra MB, Fisher LD, et al: Risks for renal dysfunction with cardiac angiography. Ann Intern Med 104:501-504, 1986
70. Anto HR, Chou S-Y, Porush JC, et al: Infusion intravenous pyelography and renal function: Effects of hypertonic mannitol in patients with chronic renal insufficiency. Arch Intern Med 141:1652-1656, 1981
71. Older RA, Korobkin M, Cleeve DM, et al: Contrast-induced acute renal failure: Persistent nephrogram as clue to early detection. Am J Roentgenol 134:339-342, 1980
72. Lang EK, Foreman J, Schlegel JU, et al: The incidence of contrast medium-induced acute tubular necrosis following arteriography: A preliminary report. Radiology 138:203-206, 1981
73. Love L, Lind JA Jr, Oison MC: Persistent CT nephrogram: Significance in the diagnosis of contrast nephropathy. Radiology 172:125-129, 1989
74. Love L, Johnson MS, Bresler ME, et al: The persistent computed tomography nephrogram: Its significance in the diagnosis of contrast-associated nephrotoxicity. Br J Radiol 67:951-957, 1994
75. Levy EM, Viscoli CM, Horwitz RI: The effect of acute renal failure in mortality. A cohort analysis. JAMA 275:1488-1494, 1996
76. Turney JH: Acute renal failure - A dangerous condition. JAMA 275:1516-1517, 1996
77. D'Elia JA, Gleason RE, Alday M, et al: Nephrotoxicity from angiographie contrast material: A prospective study. Am J Med 72:719-724, 1982
78. Cramer BC, Parfrey PS, Hutchinson TA, et al: Renal function following infusion of radiologie contrast material: A prospective controlled study. Arch Intern Med 145:87-89, 1985
79. Moore RD, Steinberg EP, Powe NR, et al: Frequency and determinants of adverse reactions induced by high-osmolality contrast media. Radiology 170:727-732, 1989
80. Davidson CJ, Hlatky M, Morris KG, et ai: Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization: A prospective trial. Ann Intern Med 110:119-124, 1989
81. Schwab SJ, Hlatky MA, Pieper KS, et al: Contrast nephrotoxicity: A randomized controlled trial of a nonionic and an ionic radiographie contrast agent. N Engl J Med 320:149-153, 1989
82. Rich MW, Crecelius CA: Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. Arch Intern Med 150:1237-1242, 1990
83. Lautin EM, Freeman NJ, Schoenfeld AH, et al: Radiocontrast-associated renal dysfunction: A comparison of lower-osmolality and conventional high-osmolality contrast media. Am J Radiol 157:59-65, 1991
84. Parfrey PS, Griffiths SM, Barrett BJ, et al: Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. N Engl J Med 320:143-149, 1989
85. Lautin EM, Freeman NJ, Schoenfeld AH, et al: Radiocontrast-associated renal dysfunction: Incidence and risk factors. Am J Roentgenol 157:49-58, 1991
86. Mason RA, Arbeit LA, Giron F: Renal dysfunction after arteriography. JAMA 253:1001-1004, 1985
87. Nunez BD, Allon M: Effect of cardiac catheterization on renal function. Clin Nephrol 34:263-266, 1990
88. Gomes AS, Baker JD, Martin-Paradero V, et al: Acute renal failure after major arteriography. Am J Roentgenol 145:1249-1253, 1985
89. Weisberg LS, Kurnik PB, Kumik BRC: Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney Int 45:259-265, 1994
90. Harkonen S, Kjellstrand CM: Intravenous pyelography in nonuremic diabetic patients. Nephron 24:268-270, 1979
91. Cigarroa RG, Lange RA, Williams RH, et al: Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med 86:649-652, 1989
92. Martin-Paradero V, Dixon SM, Baker JD, et al: Risk of renal failure after major angiography. Arch Surg 118:1417-1420, 1983
93. Swartz RD, Rubin JE, Learning BW, et al: Renal failure following major angiography. Am J Med 65:31-37, 1978
94. Smolens P: The kidney in dysproteinemic states. AKF Nephrol Letter 4:27-42, 1987
95. Huang ZQ, Kirk KA, Connell KG, et al: Bence Jones proteins bind to a common peptide segment of Tamm-Horsfall glycoprotein to promote heterotypic aggregation. J Clin Invest 92:2975-2983, 1993
96. Sanders PW, Booker BB: Pathobiology of cast nephropathy from human Bence Jones proteins. J Clin Invest 89:630-639, 1992
97. Lasser EC, Lang JH, Zawadzki ZA: Contrast mediamyeloma protein precipitates in urography. JAMA 198:945-947, 1966
98. Schwartz RH, Berdon WE, Wagner HE: Tamm-Horsfall urinary microprotein precipitation by urographie contrast agents. Am J Roentgenol 100:698-701, 1970
99. McCarthy CS, Becker JA: Multiple myeloma and contrast media. Radiology 183:519-521, 1992
100. Defronzo RA, Humphrey RL, Wright JR, et al: Acute renal failure in multiple myeloma. Medicine 54:209-223, 1975
101. Kyle RA: Multiple myeloma. Review of 869 cases. Mayo Clin Proc 50:29-40, 1975
102. Cohen DJ, Sherman WH, Osserman EF, et al: Acute renal failure in patients with multiple myeloma. Am J Med 76:247-256, 1984
103. McClennan BL: Low-osmolality contrast media: Premises and promises. Radiology 162:1-8, 1987
104. Spataro RF: New contrast agents for urography. Radiol Clin North Am 22:365-380, 1984
105. McClennan BL, Stolberg HO: Intravascular contrast media. Ionic versus nonionic: Current status. Radiol Clin North Am 29:437-454, 1991
106. Russel SB, Biol LI, Sherwood T: Monomere/dimere contrast media in the renal circulation: Experimental angiography. Br J Radiol 47:268-271, 1974
107. Morris TW, Katzberg RW, Fisher HW: A comparison of the hemodynamic responses to metrizamide and meglumine/sodium diatrizoate in canine renal angiography. Invest Radiol 13:74-78, 1978
108. Lund G, Rysavy J, Salmonowitz E, et al: Nephrotoxicity of contrast media assessed by occlusion arteriography. Radiol 152:615-619, 1984
109. Tornquist C, Almen T, Golman K, et al: Renal function following nephroangiography with metrizamide and iohexol. Effects on renal blood flow, glomerular permeability and filtration rate and diuresis in dogs. Acta Radiol Diag 26:483-489, 1985
110. Katzberg RW, Morris TW, Lasser EC, et al: Acute systemic and renal hemodynamic effects of meglumine/sodium diatrizoate 76% and iopamidol in euvolemic and dehydrated dogs. Invest Radiol 21:793-797, 1986
111. Deray G, Baumelou B,MartinezF, et al: Renal vasoconstriction after low and high osmolar contrast agents in ischemic and nonischemic canine kidneys. Clin Nephrol 36:93-96, 1991
112. Hollas S, Tejler L: Proteinuria following nephro-angiography. IV. Comparison in dogs between ionic and nonionic contrast media. Acta Radiol Diag 20:13-18, 1979
113. Thomsen HS, Hemmingsen L, Golman K, et al: Low sodium diet, indomethacin, and contrast media. A comparison between renal effects of diatrizoate and iohexol in rats. Acta Radiol 31:613-618, 1990
114. Thomsen HS, Dorph S, Mygind T, et al: Urine profiles following intravenous diatrizoate, iohexol, or ioxilan in rats. Invest Radiol (Suppl 1) 23:S168-S170, 1988
115. Deray G, Dubois M, Martinez F, et al: Renal effects of radiocontrast agents in rats: A new model of acute renal failure. Am J Nephrol 10:507-513, 1990
116. Golman K, Almen T: Contrast media-induced nephrotoxicity. Survey and present state. Invest Radiol (Suppl) 20:S92-S97, 1985
117. Messana JM, Cielinski DA, Nguyen VD, et al: Comparison of the toxicity of the radiocontrast agents iopamidol and diatrizoate to rabbit renal proximal tubule cells in vitro. J Pharmacol Exp Ther 244:1139-1144, 1988
118. Oldroyd S, Haylor J, Morcos SK, et al: Reduced depression of renal function by iotrolan in the isolated rat kidney. Eur J Radiol 18:64-69, 1994
119. Cedgard S, Herlitz H, Geterud K, et al: Acute renal insufficiency after administration of low-osmolar contrast media. Lancet 2:1281, 1986
120. Evans JR, Shankel SW, Cutler RE: Low osmolar contrast agents and nephrotoxicity. Ann Intern Med 107:116, 1987
121. Aron NB, Feinfeld DA, Peters AT, et al: Acute renal failure associated with ioxaglate, a low-osmolality radiocontrast agent. Am J Kidney Dis 13:189-193, 1989
122. Gomes AS, Lois JF, Baker JD, et al: Acute renal dysfunction in high-risk patients after angiography: Comparison of ionic and nonionic contrast media. Radiology 170:65-68, 1989
123. Deray G, Bellin M-F, Boulechfar H, et al: Nephrotoxicity of contrast media in high-risk patients with renal insufficiency: Comparison of low and high-osmolar contrast agents. Am J Nephrol 11:309-312, 1991
124. Barrett BJ, Carlisle EJ: Metaanalysis of the relative nephrotoxicity of high and low-osmolality iodinated contrast media. Radiology 188:171-178, 1993
125. Harnish PP, Fountaine H, Ebrahimi R: lodixanol: Experience in 1,259 patients in the United States. Invest Radiol 29:5236-3237, 1994
126. Grynne BH, Nossen JO, Bolstad B, et al: Main results of the first comparative clinical studies on Visipaque. Acta Radiol 36:265-270, 1995 (Suppl 399)
127. Jakobsen JA: Renal effects of iodixinol in healthy volunteers and patients with severe renal failure. Acta Radiol 36:191-195, 1995 (Suppl 399)
128. Walday P, Heglund IF, Golman K, et al: Renal effects of iodixinol in experimental animals. Acta Radiol 36:204-212, 1995 (Suppl 399)
129. Uchimoto R, Miyazawa T, Fritz-Zieroth B: Effects of iotrolan, iopamidol, and iopromide in rats with and without experimental nephropathy. Invest Radiol 19:5111-5112,1994
130. Rudnick MR, Goldfarb S, Murphy MJ: Mannitol and other prophylactic regimens in contrast media-induced acute renal failure. Coronary Artery Dis 2:1047-1052, 1991
131. Van RD, Natarajan LP, Whitescarver SA, et al: Induction, prevention and mechanisms of contrast media-induced acute renal failure. Kidney Int 33:699-707, 1988
132. Old CW, Duarte CM, Lehrner LM, et al: A prospective evaluation of mannitol in the prevention of radiocontrast acute renal failure. Clin Res 29:472A, 1981 (abstr)
133. Vosnides GR, Kalogeropoulos V, Spanos H, et al: Radiocontrast-induced deterioration of renal function in patients with chronic renal failure. Abstracts of the Eighth International Congress of Nephrology. Athens, Greece, University Studio Publishing, 1981, p 306 (abstr)
134. Solomon R, Werner C, Mann D, et al: Effects of saline, mannitol and furosemide on acute decreases in renal function induced by radiocontrast agents. N EngI J Med 331:1416-1420, 1994
135. Ghandour F, Larranaga J, Manon A, et al: The effect of mannitol (M) on the development of contrast-associated nephropathy (CAN) in patients with chronic renal insufficiency (CRI). J Am Soc Nephrol 6:464, 1995 (abstr)
136. Eisenberg RL, Bank WO, Hedgock MW: Renal failure after major angiography can be avoided with hydration. Am J Radiol 136:859-861, 1981
137. Brown RS, Ransil B, Clark BA: Prehydration protects against contrast nephropathy in high risk patients undergoing cardiac catheterization. J Am Soc Nephrol 1:330,1990 (abstr)
138. Heyman SN, Brezis M, Greenfeld Z, et al: Protective role of furosemide and saline in radiocontrast-induced acute renal failure in the rat. Am J Kidney Dis 14:377-385, 1989
139. Oguagha C, Porush JG, Chou S Y, et al: Prevention of acute renal failure (ARF) following infusion intravenous pyelography (IVP) in patients with chronic renal insufficiency (CRI) by furosemide (F). Abstracts of the Eight International Congress of Nephrology. Athens, Greece, University Studio Publishing, 1981, p 290 (abstr)
140. Beronaide VC: Prevention of acute renal failure secondary to radiocontrast agents. Abstracts of the Eight International Congress of Nephrology. Athens, Greece, University Studio Publishing, 1991, p 380 (abstr)
141. Weinstein J-M, Heyman S, Brezis M: Potential deleterious effect of furosemide in radiocontrast nephropathy. Nephron 62:413-415, 1992
142. Deray G, Martinez R, Cacoub P, et al: A role for adenosine calcium and ischemia in radiocontrast-induced intrarenal vasoconstriction. Am J Nephrol 10:316-322, 1990
143. Neumayer HH, Junge W, Kufner A, et al: Prevention of radiocontrast media-induced (CM) nephrotoxicity by the calcium antagonist (CA) nitrendipine: A prospective randomized clinical trial. Am Soc Nephrol 72A, 1989 (abstr)
144. Wilding M, Kampf D, Jun MS, et al: Nitrendipine (N) and nephrotoxicity of nonionic contrast media: A randomized controlled clinical trial. J Am Soc Nephrol 2:671,1991 (abstr)
145. Pourrai JP, Douste-Blazy P: Renal side effect of nifedipine. Clin Cardiol 7:29-30, 1984
146. Fenves AZ, Allgren RL for the Auriculin Anaritide ARF Study Group: Radiocontrast dye-induced acute tubular necrosis (ATN): atrial natriuretic peptide (ANP) versus placebo. J Am Soc Nephrol 6:463, 1995 (abstr)
147. Waaler A, Svalend M, Fouchald P, et al: Elimination of iohexol, a low osmolar contrast medium by hemodialysis in patients with chronic renal failure. Nephron 56:81-85, 1990
148. Moon SS, Bäak SE, Kurkus J, et al: Hemodialysis for elimination of the nonionic contrast medium iohexol after angioplasty in patients with impaired renal function. Nephron 70:430-437, 1995
149. Lehnen T, Gondolf K, Schaffner T, et al: Effect of hemodialysis after contrast media application in adults with renal insufficiency. J Am Soc Nephrol 6:469, 1995 (abstr)
150. Lee JKTL, Warshaver DM, Bush WH Jr, et al: Determination of serum creatinine level before intravenous administration of iodinated contrast media. A survey. Invest Radiol 30:700-705, 1995